Lyell Immunopharma, Inc. — SC 13G/A Filings
5 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by Lyell Immunopharma, Inc. (LYEL), sorted by most recent first. Each row links to the full filing on EdgarLookup. Lyell Immunopharma, Inc. has filed 5 SC 13G/A documents with the SEC since 2020. To view all SEC filings by Lyell Immunopharma, Inc., see the full filings list.
All
10-K
10-Q
144
3
4
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | — | 0000932471-24-001105 | Nov 12, 2024 | — |
| SC 13G/A | — | 0000932471-24-000620 | Nov 4, 2024 | — |
| SC 13G/A | ARCH VENTURE FUND IX, L.P. - LYELL IMMUNOPHARMA -- SCH 13G/A(#1) | 0001072613-24-000252 | Feb 14, 2024 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-24-021383 | Feb 13, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-23-019827 | Feb 13, 2023 | — |